» Articles » PMID: 34129195

MicroRNA-9 inhibits proliferation and Progression In retinoblastoma Cells By targeting PTEN

Overview
Journal Genes Genomics
Specialty Genetics
Date 2021 Jun 15
PMID 34129195
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Retinoblastoma (RB) is the most prevalent primary intraocular malignancy, which commonly occurs during infant and childhood.

Objective: Our study aimed to investigate whether microRNA-9 (miR-9) could regulate RB cells and its mechanism.

Methods: qRT-PCR analysis was used to detect the expression of miR-9. In addition, to detect the migration of RB cells, wound healing assay was conducted. Xenograft tumor models in nude mice were also established, in order to assess the effects of miR-9 on tumor growth. qRT-PCR, luciferase reporter assay and western blot analysis were used to detect the target of miR-9.

Results: Initially, the expression level of miR-9 was significantly decreased in the RB tissues and blood samples from patients with RB. qRT-PCR, luciferase reporter assay and western blot analysis were used to confirm that PTEN was the target genes of miR-9 and it was negatively regulated by miR-9. When the expression of miR-9 was up-regulated, the cell viability, proliferation, migration and tumor formation were significantly suppressed. Furthermore, the expression level of PTEN was decreased after transfection of miR-9 mimic. Taken together, these results indicated that miR-9 might suppress the cell viability, proliferation, migration and tumor formation in RB by inhibiting PTEN.

Conclusion: The in vitro and in vivo experiments demonstrated that miR-9 acts as a tumor suppressor function in RB cells and might serve as novel therapeutic targets for the treatment of RB.

Citing Articles

MicroRNAs' Significance in Retinoblastoma Diagnosis and Treatment: The Little Heroes.

Zamani Sani M, Mirzaei M, Mota A, Mohammadian J, Beilankouhi E, Rahmati M Biochem Genet. 2025; .

PMID: 39862293 DOI: 10.1007/s10528-024-10976-2.


Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression.

Ahangar Davoodi N, Najafi S, Ghale-Noie Z, Piranviseh A, Mollazadeh S, Ahmadi Asouri S Front Cell Dev Biol. 2023; 10:1065837.

PMID: 36619866 PMC: 9816416. DOI: 10.3389/fcell.2022.1065837.


Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia.

Pal R, Kowalik M, Serra M, Migliore C, Giordano S, Columbano A Cell Prolif. 2022; 55(4):e13199.

PMID: 35174557 PMC: 9055901. DOI: 10.1111/cpr.13199.

References
1.
Abramson D, Shields C, Munier F, Chantada G . Treatment of Retinoblastoma in 2015: Agreement and Disagreement. JAMA Ophthalmol. 2015; 133(11):1341-7. DOI: 10.1001/jamaophthalmol.2015.3108. View

2.
Braga E, Loginov V, Filippova E, Burdennyi A, Pronina I, Kazubskaya T . Diagnostic Value of a Group of MicroRNA Genes Hypermethylated in Ovarian Carcinoma. Bull Exp Biol Med. 2018; 166(2):253-256. DOI: 10.1007/s10517-018-4326-0. View

3.
Cai B, Ma W, Ding F, Zhang L, Huang Q, Wang X . The Long Noncoding RNA CAREL Controls Cardiac Regeneration. J Am Coll Cardiol. 2018; 72(5):534-550. DOI: 10.1016/j.jacc.2018.04.085. View

4.
Cao Y, Xia F, Wang P, Gao M . MicroRNA‑93‑5p promotes the progression of human retinoblastoma by regulating the PTEN/PI3K/AKT signaling pathway. Mol Med Rep. 2018; 18(6):5807-5814. DOI: 10.3892/mmr.2018.9573. View

5.
Carvalho I, Reis A, Cabello P, Vargas F . Polymorphisms of CDKN1A gene and risk of retinoblastoma. Carcinogenesis. 2013; 34(12):2774-7. DOI: 10.1093/carcin/bgt308. View